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OBJECTIVES: The use of thymidine NRTI (tNRTI) drugs for treatment of HIV, specifically stavudine 
and zidovudine, increases the risk of developing lipoatrophy – a pathology of the adipose tissue 
involving reduction in mitochondrial (mt) DNA copy numbers per adipocyte, tissue fibrosis and 
increased adipocyte death. Adipose tissue pathology in other settings represents a significant risk for 
cardiovascular health.
METHODS: To elucidate the pathogenesis of lipoatrophy, we have quantified proportional fat loss by 
DEXA-measured leg fat percentage normalized by body mass index (BMI), adipocyte tissue mtDNA by 
qPCR, adipose tissue macrophages by histological evaluation and adipokine expression (including IL-6, 
IL-8, TNF-α, MCP-1, HGF, resistin and adiponectin in fat and plasma samples) by lincoplex and 
luminex technology. Adipose tissue biopsies were obtained from consenting study participants from the 
West Australian observational HIV cohort, including samples from NRTI-treated patients (stavudine 
n=37, zidovudine n=65 and abacavir n=45) and ART-naïve patients (n=50).
RESULTS: Significant mtDNA depletion in subcutaneous fat was specifically associated with tNRTI 
treatment (P≤0.0001), with a more pronounced effect of stavudine > zidovudine (P<0.05). Values for 
abacavir NRTI therapy were comparable with ART-naïve samples (P=0.2). Adipocyte mtDNA depletion 
occurred relatively early (within 6 months) on tNRTI therapy and then equilibrated to a drug-specific 
level, whereas limb fat loss occurred more slowly over 1–3 years. During tNRTI therapy, nadir leg fat 
percentage/BMI correlated with increases in the number of adipose tissue macrophages (P<0.0001), as 
well as decreases in plasma adiponectin (P<0.05). Plasma adiponectin also correlated negatively with 
tissue protein expression of IL-6, IL-8, MCP-1 and HGF (P<0.05). Examining paired tissue samples 
from 15 individuals pre- and post-tNRTI switching, we found partial normalization of mtDNA, in that 
values were still significantly lower than ART-naïve individuals (P=0.01 after 1–6 months and P=0.05 
after 8 months), but were also significantly increased from pre-switch levels (P≤0.01). Upon switching 
from thymidines, increases in adipocyte mtDNA correlated with decreases in adipose tissue 
inflammatory-related proteins leptin, MCP-1, HGF, resistin, PAI, IL-6 and IL-8 (P=0.005). We found 
poor correlations between the same analyte in plasma versus tissue measured at similar time points, with 
the exception of MCP-1 and IL-8 (r≥0.5 for both). Individuals with more severe lipoatrophy, as assessed 
by nadir leg fat percentage/BMI, showed less reduction in tissue expression of IL-6, IL-8, MCP-1 and 
HGF after switching from tNRTI treatment.
CONCLUSIONS: The study demonstrates that lipoatrophy shares a number of histopathological 
features with obesity, including adipose tissue inflammation and macrophage infiltration, although in 
this case adipocyte-specific mt toxicity appears to be a primary pathogenic mechanism. Those with most 
severe pathology appear to show the poorest recovery.
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